Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.6%

2 terminated out of 36 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

71% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (23)
P 1 (1)
P 2 (2)
P 4 (1)

Trial Status

Recruiting21
Completed5
Not Yet Recruiting5
Active Not Recruiting2
Terminated2
Enrolling By Invitation1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT07137572Not ApplicableCompleted

Arts-based Social Prescribing for Mental Health

NCT07010614Not ApplicableRecruitingPrimary

Brain Stimulation to the Hippocampus in Schizophrenia

NCT06641297Not ApplicableRecruitingPrimary

White Matter Plasticity in Schizophrenia

NCT06957808Not ApplicableRecruitingPrimary

Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia

NCT06939088Phase 2Recruiting

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

NCT07398365Recruiting

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

NCT07098169Not ApplicableRecruitingPrimary

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

NCT06674694Phase 1RecruitingPrimary

The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

NCT06911931Not ApplicableRecruitingPrimary

Visual Perception in Schizophrenia

NCT06641726Recruiting

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness

NCT07091344Not ApplicableRecruitingPrimary

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

NCT06911723Not ApplicableRecruitingPrimary

Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls

NCT07082777Not ApplicableRecruitingPrimary

Recovery in Telling Life Stories

NCT07055204Not ApplicableNot Yet RecruitingPrimary

Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia

NCT06949657Not ApplicableTerminatedPrimary

Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and

NCT07027085Not ApplicableActive Not RecruitingPrimary

Investigation of the Effects of Virtual Reality Applications on Individuals Diagnosed With Schizophrenia

NCT06978803Recruiting

HYEEG Discourse in Psychosis: A Neurobehavioural Study

NCT06978465Not Yet Recruiting

DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis

NCT06978881Enrolling By InvitationPrimary

Magnetoencephalography in Psychosis Program

NCT06972745Not ApplicableTerminatedPrimary

Efficacy & Tolerability of Rigth Unilateral vs. Bitemporal ECT in Schizophrenia in a Psychiatric Hospital in Mexico

Scroll to load more

Research Network

Activity Timeline